ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979